Welcome to our dedicated page for Strata Skin Sciences news (Ticker: SSKN), a resource for investors and traders seeking the latest updates and insights on Strata Skin Sciences stock.
Strata Skin Sciences Inc (SSKN) provides innovative medical technologies for dermatology practices, specializing in excimer laser treatments for conditions like psoriasis and vitiligo. This news hub offers investors and healthcare professionals timely updates on SSKN's financial developments, product innovations, and strategic partnerships.
Access official press releases covering quarterly earnings, FDA clearances, clinical study results, and partnership expansions with dermatology clinics. Our curated collection simplifies tracking SSKN's progress in advancing in-office phototherapy solutions and its unique recurring revenue model.
Discover updates about the XTRAC® excimer laser system, VTRAC™ lamp technologies, and SSKN's practice support programs. Content is organized chronologically for quick reference, with clear sourcing for regulatory filings and corporate announcements.
Bookmark this page to stay informed about SSKN's position in the $12B+ global dermatology devices market. Verify all information directly with SEC filings or company communications before making financial decisions.
STRATA Skin Sciences (NASDAQ: SSKN), a medical technology company focused on dermatologic treatments, announces its upcoming third quarter 2024 financial results release on November 13, 2024, after market close. Management will host a conference call at 4:30 p.m. ET the same day, including a Q&A session. U.S. participants can dial 1-844-481-2523, while international callers should use 1-412-317-0552. A webcast replay will be available until May 13, 2025, and a telephonic replay until November 20, 2024, using access code 4851779.
STRATA Skin Sciences, Inc. (NASDAQ: SSKN) announced that its Japanese distributor, JMEC Co., , sponsored a seminar featuring two lectures on XTRAC® excimer devices at the 75th Annual Meeting of the Chubu Branch of the Japanese Dermatological Association in Nagoya, Japan on October 12, 2024. The seminar, chaired by Professor Kazutoshi Harada of Tokyo Medical University, included presentations by:
1. Dr. Nobuhiro Nouchi from Nouchi Dermatology Clinic, discussing successful treatment of vitiligo and alopecia areata using XTRAC® excimer laser.
2. Dr. Osamu Norisugi from Keyaki Dermatology Clinic, sharing his clinic's experience in treating psoriasis, vitiligo, and alopecia areata with XTRAC® excimer laser since 2020.
This event highlights the growing recognition and use of STRATA's XTRAC® technology in the Japanese dermatology market.
STRATA Skin Sciences (NASDAQ: SSKN), a medical technology company focused on dermatologic treatments, announces its participation in the 2024 Maxim Healthcare Virtual Summit. President and CEO Dr. Dolev Rafaeli will engage in a fireside chat with Maxim's Director of Research and Senior Healthcare Analyst Anthony Vendetti on Wednesday, October 16, 2024, at 11:30am ET.
The virtual conference runs from October 15 to 17, 2024. Investors can access the fireside chat via webcast at https://m-vest.com/events/healthcare-10152024. Additionally, Dr. Rafaeli and STRATA V.P. Finance John Gillings will be available for one-on-one meetings with registered conference investors.
STRATA Skin Sciences (NASDAQ: SSKN), a medical technology company focused on dermatologic conditions, announces its participation in the iAccess Alpha - Buyside Best Ideas Fall Conference 2024. The virtual event is scheduled for September 24-25, 2024.
Key details:
- President and CEO Dr. Dolev Rafaeli will present a corporate overview on September 24, 2024, at 12:30 PM ET
- Presentation webcast available at: https://www.webcaster4.com/Webcast/Page/3064/51242
- Dr. Rafaeli and V.P. Finance John Gillings will be available for one-on-one meetings with registered investors
- Investors can register and schedule meetings at: https://www.iaccessalpha.com/signup
This presentation offers an opportunity for investors to gain insights into STRATA's innovative products and market strategy in the dermatology sector.
STRATA Skin Sciences (NASDAQ: SSKN), a medical technology company focused on dermatologic treatments, has announced its participation in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference. The event is scheduled for September 12, 2024, at the Yale Club in Midtown Manhattan, New York City.
Dr. Dolev Rafaeli, President and CEO of STRATA, will represent the company at the conference. STRATA will be hosting one-on-one investor meetings throughout the event, providing an opportunity for investors to engage directly with the company's leadership. Interested parties can schedule meetings through their Lake Street representatives.
This participation underscores STRATA's commitment to investor relations and its ongoing efforts to showcase its innovative products in the dermatologic field to potential investors and industry professionals.
STRATA Skin Sciences (NASDAQ: SSKN), a medical technology company focused on dermatologic treatments, announces its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The event will take place from September 9-11, 2024 at the Lotte New York Palace Hotel.
Key points:
- President and CEO Dr. Dolev Rafaeli will present a corporate overview
- Presentation will be available on-demand starting September 9, 2024, at 7:00 am ET
- Investors can register for the conference at https://hcwevents.com/annualconference/
- Dr. Rafaeli and V.P. Finance John Gillings will be available for one-on-one meetings with registered investors
STRATA Skin Sciences (NASDAQ: SSKN) has filed a complaint against LaserOptek, Monarch Laser Services (MLS), and The Pinnacle Health Group for unfair competition and false advertising regarding the marketing and sales of Pallas laser devices. The lawsuit, filed in the U.S. District Court for the Eastern District of Pennsylvania, alleges that the defendants:
- Misrepresented the reimbursement eligibility of Pallas lasers for psoriasis treatments
- Made false claims about the equivalence and superiority of Pallas lasers to STRATA's XTRAC® devices
- Misused FDA clearance to make misleading statements
- Caused harm to public interest through fraudulent reimbursement practices
STRATA seeks injunctive relief, damages, and legal cost reimbursement to protect its 4,000 partners and patients using their proven excimer devices for dermatology treatments.
STRATA Skin Sciences (NASDAQ: SSKN) reported Q2 2024 financial results and provided a corporate update. Key highlights include:
- Revenue increased 2% YOY to $8.4 million
- Gross profit margin improved to 58.5% from 52.3% last year
- Operating expenses decreased 14% YOY to $5.4 million
- Net loss narrowed to $0.1 million ($0.03 per share) from $3.1 million ($0.90 per share) in Q2 2023
- Cash balance increased to $6.8 million
- Domestic XTRAC installed base decreased to 882 devices as the company optimizes its asset base
- TheraClear X installed base grew to 117 devices
- Completed a $2.1 million financing in July 2024
The company is focusing on DTC marketing and optimizing its device installed base to drive growth and profitability.
STRATA Skin Sciences (NASDAQ: SSKN), a medical technology company focused on dermatologic treatments, has announced its plans to report second quarter 2024 financial results on August 14, 2024, after market close. The company will host a conference call at 4:30 p.m. ET on the same day to discuss the results and provide a corporate update.
Interested parties can join the call by dialing 1-877-270-2148 (domestic) or 1-412-902-6510 (international). A live webcast will also be available. A telephonic replay will be accessible until August 21, 2024, and a webcast replay will be available until February 14, 2025.
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company focused on dermatologic treatments, has announced its participation in the 9th Annual Virtual Needham MedTech & Diagnostics 1x1 Conference. The event is scheduled for August 12-13, 2024.
Key points:
- Dr. Dolev Rafaeli, President and CEO, and Christopher Lesovitz, CFO, will represent STRATA
- They will be available for one-on-one meetings on both conference days
- Investors can arrange meetings by contacting IR@strataskin.com
This participation demonstrates STRATA's commitment to engaging with investors and showcasing their innovative dermatologic products and technologies.
FAQ
What is the current stock price of Strata Skin Sciences (SSKN)?
What is the market cap of Strata Skin Sciences (SSKN)?
